Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cisplatin (platinol) (6 trials)
gemcitabine (gemzar) (8 trials)
gimeracil (6 trials)
oteracil (6 trials)
s-1 (6 trials)
tegafur (6 trials)
fluorouracil (efudex) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Biliary Tract Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Trials (9 total)
Trial APIs (8 total)